1. 基于AI多模态临床参数的认知障碍精准诊疗模型构建

Construction of a Precision Diagnosis and Treatment Model for Cognitive Impairment Based on AI Multimodal Clinical Parameters

2. 靶向清除病理性TAU蛋白的作用和机制研究

Role and Mechanism of Targeted Clearance of Pathological Tau Protein

同济大学附属东方医院北院神经内科主任、同济大学脑血管病研究中心副主任（兼）秘书长 、中华医学会心身医学分会老年心身学组副组长、中国老年医学学会认知障碍分会常委、上海市医学会神经病学分会委员、上海市医师协会神经病学分会委员、上海市卒中学会青年工作委员会副会长、上海市医学会痴呆与认知功能障碍副组长、上海市医学会缺血性卒中规范化诊治副组长、上海市社会医疗机构协会神经病学分会副主任委员。

Director, Department of Neurology, North Branch of Tongji University Affiliated Oriental Hospital;

Deputy Director (concurrently) and Secretary-General, Cerebrovascular Disease Research Center of Tongji University;

Vice Chair, Geriatric Psychosomatics Group, Chinese Society of Psychosomatic Medicine;

Standing Committee Member, Cognitive Impairment Branch, Chinese Geriatric Society;

Member, Neurology Society of Shanghai Medical Association;

Member, Neurology Branch of Shanghai Medical Doctor Association;

Vice President, Youth Working Committee, Shanghai Stroke Association;

Deputy Leader, Dementia and Cognitive Impairment Group, Shanghai Medical Association;

Deputy Leader, Standardized Diagnosis and Treatment Group for Ischemic Stroke, Shanghai Medical Association;

Vice Chair, Neurology Branch of Shanghai Social Medical Institutions Association.

承担国家级课题3项、省部级课题6项，合计16项基金；以第一/通讯作者在APSB、Small、Transl Neurodegener等国际知名杂志发表SCI论文45篇；第一申请人获国防、发明专利等授权16项；主编专著3部，参编国家级教材3部 。

Undertook 16 research projects (including 3 national-level and 6 ministerial/ provincial-level projects). Published 45 SCI papers as first/corresponding author in internationally renowned journals such as APSB, Small, and Translational Neurodegeneration. Obtained 16 authorized patents as first applicant (including national defense and invention patents). Authored 3 academic monographs as chief editor and contributed to 3 national textbooks as co-author.